ESMO Targeted Anticancer Therapies Congress 2025

Abstracts: Open Access
Slides and Webcasts: Available to ESMO Members and registered delegates, subject to presenters' consent

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

The ESMO TAT Congress is dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical and early clinical data.ESMO TAT 2025 is a multi-stakeholder forum in the early drug development arena, which bring together investigators from academia, translational scientists, methodological experts and opinion leaders from industry, investor and regulatory bodies to highlight new data, promote collaboration and tackle challenges for accelerating the bench-to-bedside pathway to the benefit of our patients

Click here to access the official Abstract book of the ESMO Targeted Anticancer Therapies, a supplement to ESMO Open.

Resources from ESMO Colloquia